Fisher & Paykel boss Lewis Gradon gets hefty pay boost after hitting targets

Fisher & Paykel boss Lewis Gradon gets hefty pay boost after hitting targets
Fisher & Paykel Healthcare and its managing director Lewis Gradon hit targets for operating revenue, profit and cashflow. (Image: NZME)
Rebecca Stevenson
New Zealand Exchange-listed medical device manufacturer Fisher & Paykel Healthcare says the feedback from US customers on its new solo mask for obstructive sleep apnea has been tremendous. Fisher & Paykel reported its full-year result to March 31 on Wednesday, reporting underlying net profit after tax of $264.4 million after stripping out one-off items including a $98m revaluation of land it purchased at Karaka. Free cashflow rose to $73.8m compared to $12.5m in the previous financial year, while operating revenue wa...

More Markets

Advent International eyes NZ deals with Aussie outpost
Markets

Advent International eyes NZ deals with Aussie outpost

US private equity giant says NZ key market for growth.

These shares are 'priced for awful'
Markets

These shares are 'priced for awful'

Kathmandu, SkyCity and Fletcher shares are under pressure. Some are taking the plunge.

NZ sharemarket drifts lower
Markets Market close

NZ sharemarket drifts lower

The S&P/NZX 50 Index closed at 11,776.73, easing 12.65 points or 0.11%.

Graham Skellern 02 Jul 2024